Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 9
Submit an article Journal homepage
631
Views
37
CrossRef citations to date
0
Altmetric
Original article

UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug

Adrian Kielhorn F. Hoffmann La-Roche Ltd, Basel, SwitzerlandCorrespondence[email protected]
,
Duncan Porter Gartnavel General Hospital, Glasgow, UK
,
Alexander Diamantopoulos M-TAG Ltd. (a division of IMS Health), London, UK
&
Gavin Lewis Roche Products Ltd, Welwyn Garden City, UK
Pages 2639-2650 | Accepted 03 Jul 2008, Published online: 06 Aug 2008

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.